Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas

Non-Hodgkin lymphomas (NHLs) encompass a diverse group of malignancies arising from B cells, T cells, and natural killer (NK) cells at various stages of differentiation. Conversely, classical Hodgkin lymphomas (cHLs) primarily feature Reed-Sternberg cells (RSCs) amid a background of reactive immune...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Domenico Ribatti, Gerardo Cazzato, Roberto Tamma, Tiziana Annese, Giuseppe Ingravallo, Giorgina Specchia
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-07-01
Subjects:	Hodgkin lymphoma immune checkpoint inhibitors non-Hodgkin lymphoma therapy PD-1/PD-L1
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1420920/full